{"organizations": [], "uuid": "0b5882ea11e7fc53ca890a89a75d8e5ac30bd981", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-amgen-expects-to-launch-migraine-d/brief-amgen-expects-to-launch-migraine-drug-this-year-idUSL1N1P40YG", "country": "US", "domain_rank": 408, "title": "BRIEF-Amgen Expects To Launch Migraine Drug This Year", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-09T18:59:00.000+02:00", "replies_count": 0, "uuid": "0b5882ea11e7fc53ca890a89a75d8e5ac30bd981"}, "author": "", "url": "https://www.reuters.com/article/brief-amgen-expects-to-launch-migraine-d/brief-amgen-expects-to-launch-migraine-drug-this-year-idUSL1N1P40YG", "ord_in_thread": 0, "title": "BRIEF-Amgen Expects To Launch Migraine Drug This Year", "locations": [], "entities": {"persons": [{"name": "bill berkrot", "sentiment": "none"}], "locations": [{"name": "humira", "sentiment": "none"}, {"name": "u.s", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "amgen inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "amgen", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 9, 2018 / 5:00 PM / Updated 15 minutes ago BRIEF-Amgen Expects To Launch Migraine Drug This Year Reuters Staff \nJan 9 (Reuters) - Amgen Inc: \n* AMGEN CEO SAYS EXPECTS TO BE ABLE TO LAUNCH AIMOVIG FOR MIGRAINE THIS YEAR \n* AMGEN SAYS EXPECTS TO LAUNCH HUMIRA BIOSIMILAR OUTSIDE U.S. THIS YEAR \n* AMGEN CEO SAYS BUSINESS DEVELOPMENT DEALS TO REMAIN PRIORITY IN 2018 \n* AMGEN CEO SAYS COMPANY IN STRONGER STRATEGIC POSITION AFTER TAX REFORM Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)", "external_links": [], "published": "2018-01-09T18:59:00.000+02:00", "crawled": "2018-01-09T19:18:18.052+02:00", "highlightTitle": ""}